The currently devastating pandemic of severe acute respiratory syndrome known as
coronavirus disease 2019 or COVID-19 is caused by the coronavirus SARS-CoV-2. Both the …

Background: Over the past 2 years of the several strategies recommended to help fight
COVID-19, nirmatrelvir/ritonavir is a novel drug shown in the EPIC-HR phase 2 to 3 clinical …

Cold water benthic environments are a prolific source of structurally diverse molecules with
a range of bioactivities against human disease. Specimens of a previously chemically …

Several options to treat hospitalized severe COVID-19 patients have been suggested. The
study aimed to describe survival in patients treated with convalescent COVID plasma (CCP) …

The COVID-19 pandemic posed a significant challenge for clinicians in managing pregnant
women, who were at high risk of virus transmission and severe illness. While the WHO …

The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel
coronavirus, partially similar to previously known coronaviruses but with a different pattern of …

Inflammatory cascades of the dysregulated inflammatory pathways in COVID-19 can cause
excessive production of pro-inflammatory cytokines and chemokines leading to cytokine …

The Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has significantly impacted the health and …

The COVID-19 pandemic has created a worldwide public health crisis that has since
resulted in 6.8 million reported deaths. The pandemic prompted the immediate response of …

Rocaglates are potent broad-spectrum antiviral compounds with a promising safety profile.
They inhibit viral protein synthesis for different RNA viruses by clamping the 5′-UTRs of …